Charting a New Phase of Trump Administration's America First Global Health Strategy in Asia, Beginning with Cambodia - United States Department of State
Apnimed Announces Strategic Monetization of Shionogi-Apnimed Sleep Science (SASS) Joint Venture Stake for $150M and Royalties, Strengthening Focus on its Wholly-Owned OSA Program, AD109